- Axxam Webinar - September 17th
- SPS 2024 (September 22-25) San Diego, CA
- SFN 2024 (October 5-9) Chicago, IL
- Pain Conference 2024 (October 28-29) Boston, MA
- SITC 2024 (November 6-10) Houston, TX
-
NEW APPLICATION: Generation of 3D iCell CardioSpheres with iCell Products
- NEW POSTER: Evaluating Transduction Efficiencies of AAV Vectors into Human iPSC-derived Cell Types
- Interview: New Opportunities for Human Stem Cells in Research and Clinical Applications
- iPSC-derived Sensory Neurons with Low Spontaneous Activity
- NEW PRODUCT: Quiescent iPSC-derived Cardiac Fibroblasts with the Ability to Proliferate and Activate
- SOT 2024 (March 10-14th) Salt Lake City, UT
- Wisconsin Stem Cell Symposium (April 17th) Madison, WI
- Membrane Physiology Symposium (April 22-23rd) Napa, CA
- ASGCT 2024 (May 7-11th) Baltimore, MD
- PROTOCOL: Measuring Microglia Phagocytosis: Kinetic Imaging on the IncuCyte
- NEW APPLICATION: Using iCell Macrophages 2.0 for Liver Immune Component Co-culture
-
Transcriptional characterization of iCell Microglia as a model for neurodegeneration and therapeutic development.Ramaswami G., et al. Scientific Reports, 2024; 14:2153
-
Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes.Raniga K., et al. Cell Stem Cell, 2024, doi.org/10.1016/j.stem.2024.01.007
- Machine learning identifies phenotypic profile alterations of human dopaminergic neurons exposed to bisphenols and perfluoroalkyls.
Di Credico A., et al. Scientific Reports, 2023; 13(1):21907 -
- News
- iCell® Induced Excitatory Neurons and iCell Macrophages 2.0 Now Available!
- Save the Date! iForum™ Innovation Showcase Webinar coming Jan 30th, 2024.
- Events:
- FCDI to Present at SLAS 2024
- Visit Us at the Annual SOT 2024 Meeting
- Neuroscience 2023 Posters are Now Available to Download!
- New Webinar Now Available On-Demand: "Assaying with iPSC-derived Cardiomyocytes: Setting the Rhythm for Early Drug Discovery"
- Application Protocols:
- Contractility Analysis of iCell® Cardiomyocytes²: Evaluating iCell Cardiomyocytes² Co-culture with iCell Cardiac Fibroblasts on the FLEXcyte 96 System
- Measuring Neural Network Activity on MEA: Co-culture of iCell Induced Excitatory Neurons with iCell Astrocytes 2.0
- Publications:
- Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
- News
-
- News
- All New iCell® Products
- iCell Induced Excitatory Neurons, iCell Cardiac Fibroblasts, and iCell Macrophages 2.0 are now available!
- Events:
- FCDI to Present at EUROTOX 2023
- Visit Us at the Annual SPS Meeting
- FCDI to Present at Neuroscience 2023
- Application Protocols:
- Neural Tri-culture Made Easy
- Bioenergetic Analysis of iCell Cardiomyocytes
- Publications:
- Split luciferase-based assay to detect botulinum neurotoxins using hiPSC-derived motor neurons
- Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
- CardioMotion: identification of functional and structural cardiotoxic liabilities in small molecules through brightfield kinetic imaging
- News
- News
- iCell® Blood-Brain Barrier Isogenic Kit Now Available
- Exciting New iCell Products on the Horizon®
- Events:
- Visit Us at BIO International Conference 2023
- Join Us at the Annual ISSCR Meeting
- FCDI to Present at 17th European DSS User's Meeting
- Publications:
- Lot-to-lot Robustness Study of Commercial Human iPSC-derived Cardiomyocytes
- Structural organization and functional analysis of compound response in 3D human iPSC-derived cardiac tri-culture microtissues
- Explore PhenoVista's Ready-2-Go Microglia Phagocytosis Assay Services
Issue highlights
Trending:
With demonstrated low spontaneous activity using both patch clamp and multielectrode array (MEA) methods, iCell Sensory Neurons enable mechanistic studies of sensory hypersensitivity and related sodium channel disorders.
Events:
Applications:
Publications:
AAV9:PKP2 improves heart function and survival in a Pkp2-deficient mouse model of arrhythmogenic right ventricular cardiomyopathy.